A detailed history of Clarius Group, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Clarius Group, LLC holds 8,265 shares of BAX stock, worth $325,393. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,265
Holding current value
$325,393
% of portfolio
0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

BUY
$32.87 - $43.55 $271,670 - $359,940
8,265 New
8,265 $276,000
Q2 2023

Aug 09, 2023

BUY
$39.98 - $47.68 $189,025 - $225,431
4,728 New
4,728 $215,000
Q2 2022

Aug 10, 2022

SELL
$63.83 - $80.0 $52,276 - $65,520
-819 Reduced 19.51%
3,378 $217,000
Q4 2021

Feb 02, 2022

BUY
$74.57 - $87.19 $57,195 - $66,874
767 Added 22.36%
4,197 $360,000
Q3 2021

Oct 18, 2021

SELL
$73.77 - $83.61 $16,081 - $18,226
-218 Reduced 5.98%
3,430 $276,000
Q2 2021

Aug 06, 2021

BUY
$80.5 - $88.01 $563 - $616
7 Added 0.19%
3,648 $294,000
Q1 2021

Apr 27, 2021

BUY
$76.38 - $86.03 $992 - $1,118
13 Added 0.36%
3,641 $307,000
Q4 2020

Jan 15, 2021

BUY
$75.39 - $82.36 $31,739 - $34,673
421 Added 13.13%
3,628 $291,000
Q3 2020

Oct 09, 2020

SELL
$78.33 - $90.73 $88,512 - $102,524
-1,130 Reduced 26.05%
3,207 $258,000
Q2 2020

Jul 08, 2020

BUY
$78.66 - $94.14 $50,578 - $60,532
643 Added 17.41%
4,337 $373,000
Q1 2020

Apr 24, 2020

BUY
$71.57 - $93.3 $54,106 - $70,534
756 Added 25.73%
3,694 $300,000
Q4 2019

Jan 22, 2020

BUY
$76.7 - $88.45 $15,263 - $17,601
199 Added 7.27%
2,938 $263,000
Q3 2019

Oct 23, 2019

BUY
$81.4 - $89.78 $18,559 - $20,469
228 Added 9.08%
2,739 $240,000
Q2 2019

Aug 02, 2019

BUY
$73.44 - $82.41 $184,407 - $206,931
2,511 New
2,511 $206,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Clarius Group, LLC Portfolio

Follow Clarius Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.